Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Moore

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Biochemical and Biophysical Research Communications|March 15, 1989
Peptide substrates and inhibitors of the HIV-1 proteaseM L Moore, W M Bryan, S A Fakhoury, et al.
Journal of Medicinal Chemistry|February 1, 1989
Structure-activity relationships of novel vasopressin antagonists containing C-terminal diaminoalkanes and (aminoalkyl)guanidinesJ F Callahan, D Ashton-Shue, H G Bryan, et al.
Journal of Medicinal Chemistry|December 1, 1985
Novel vasopressin analogues that help define a minimum effective antagonist pharmacophoreW F Huffman, F E Ali, W M Bryan, et al.
Biochemistry|September 6, 1991
Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 18O isotope exchangeL J Hyland, T A Tomaszek, G D Roberts, et al.
Journal of Virology|March 10, 2017
Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More EffectiveS Boyoglu-Barnum, S O Todd, J Meng, et al.
Journal of Virology|May 5, 2017
Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion ProteinA Leemans, M De Schryver, W Van der Gucht, et al.
Urologic Oncology|June 9, 2018
Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."D E Thomas, H Z Kaimakliotis, K R Rice, et al.
Nature|February 1, 2023
Measurement of the axial vector form factor from antineutrino-proton scatteringT Cai, M L Moore, A Olivier, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Biochemical and Biophysical Research Communications|March 15, 1989
Peptide substrates and inhibitors of the HIV-1 proteaseM L Moore, W M Bryan, S A Fakhoury, et al.
Journal of Medicinal Chemistry|February 1, 1989
Structure-activity relationships of novel vasopressin antagonists containing C-terminal diaminoalkanes and (aminoalkyl)guanidinesJ F Callahan, D Ashton-Shue, H G Bryan, et al.
Journal of Medicinal Chemistry|December 1, 1985
Novel vasopressin analogues that help define a minimum effective antagonist pharmacophoreW F Huffman, F E Ali, W M Bryan, et al.
Biochemistry|September 6, 1991
Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 18O isotope exchangeL J Hyland, T A Tomaszek, G D Roberts, et al.
Journal of Virology|March 10, 2017
Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More EffectiveS Boyoglu-Barnum, S O Todd, J Meng, et al.
Journal of Virology|May 5, 2017
Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion ProteinA Leemans, M De Schryver, W Van der Gucht, et al.
Urologic Oncology|June 9, 2018
Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."D E Thomas, H Z Kaimakliotis, K R Rice, et al.
Nature|February 1, 2023
Measurement of the axial vector form factor from antineutrino-proton scatteringT Cai, M L Moore, A Olivier, et al.
Pageof 11